Designing a Novel Technique to Determine Patient Suitability for Brain Cancer Clinical Trials
Overview
Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) are the most lethal form of brain cancer in adults and children respectively. There are clinical trials aimed at trying to kill these tumors. Some clinical trials are using viruses that target brain tumors and destroy them. While there are some reports of success of viral therapy, not all tumors respond equally to this type of therapy. The focus of this project was to screen adult GBM and pediatric DIPG cell lines to see if they express an antiviral protein, interferon inducible transmembrane protein-1 (IFITM-1). Additional studies were performed to see if IFITM-1 proteins can be shed from tumor cells in culture and then test if shed IFITM-1 can be detected in the serum of cancer patients. The hypothesis of this study is that brain tumors that express IFITM-1 will be more resistant to viral therapy than tumors that do not express this protein. If we can detect this protein circulating in the blood of cancer patients, it might mean that they may not respond well to viral therapy. The results from my studies found IFITM-1 expressed in 5 of 6 GBM cell lines studied and 5 out of 7 DIPG cell lines studied. This is the first study to demonstrate the presence of IFITM-1 in shed microparticles from tumor cell lines, which could lead to future studies looking at these proteins in the blood of cancer patients to predict if they will be good candidates for viral therapy.
Competition history
- ISEF 2016
Resources
Related projects
CSEF · 2018
The Application of Exosomes for Diagnostics and Prognostics in Brain Tumors: Medulloblastoma and Glioblastoma
CSEF · 2006
Human Dendritic Cells as a Clinical Tool to Cure Human Brain Tumors
CSEF · 2016
Accelerating Cancer Immunotherapy: Optimization of an EGFRvIII-based Cancer Vaccine for Improved Glioblastoma Prognosis
AJAS · 2025
In Vitro Approach to Identify Preclinical Drug Targets to Treat Glioblastoma Multiforme
CSEF · 2014
Targeted Cancer Therapy and Diagnosis: Analyzing miRNA Expression Signatures & Interactions for Glioblastoma Progression
ISEF · 2014
Progressing Targeted Cancer Therapy and Diagnosis: Analyzing the Role of MiRNA Target Interactions and Expression Signatures for Glioblastoma Progression
ISEF · 2023
Innovative Combination Therapy for Treating Brain Tumors: Using Avatar Models to Help Improve Patient Outcomes
CWSF · 2026
AAV Based Combination Therapies to Improve Glioblastoma Treatment Efficacy
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair